Malathi, D. C., K. Janakiraman, S. V. A. Thangavelu, and D. Ravichandran. “Enlicitide (Lipfendra): The First Oral PCSK9 Inhibitor - from Macrocyclic Peptide Innovation to Clinical Translation”. International Journal of Basic & Clinical Pharmacology, vol. 15, no. 5, Aug. 2026, pp. 1126-34, doi:10.18203/2319-2003.ijbcp20262890.